The company leverages ‘Swiss Made’ engineering and brings much-needed innovation to support scalable production of Cell and Gene Therapy products. Award-winning technology combines a bioreactor and a centrifuge into one single vessel for the first time, a new approach gentler to patient cells during process steps. Limula is currently onboarding selected cell therapy developers to run pilots while financing will be used to further advance the development of the proprietary platform. Lausanne, Switzerland – May 21, 2024; Over the last decade, several breakthrough Cell and Gene Therapy products have been approved in the USA and Europe to turn stem cells and immune cells into ‘living cures’, bringing hope to millions living with life-threatening conditions. However, these treatments remain out of … Continue reading Limula raises $6.8M to democratise access to life-saving Cell and Gene Therapies with Swiss-made manufacturing platform